Contraceptive Agents: Clinical Trials

10 trials of Contraceptive Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 terminated, 1 unknown. 4 Phase 4, 2 Phase 3, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Terminated 1
Phase 32Completed 1, Unknown 1
Early Phase 11Completed 1
Phase 11Completed 1

Follow Contraceptive Agents: new trials by email Literature Review of Contraceptive Agents trials Research Report on Contraceptive Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
NNC0487-0111 A, NNC0487-0111 C, Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC) - Obesity
Phase 1CompletedNovo Nordisk A/S432024-06-142025-05-08
Inpatient Adolescent Contraception
SexHealth II, Contraceptive - Pregnancy Related, Contraception
Early Phase 1CompletedChildren's Mercy Hospital Kansas City252020-12-102023-04-05
Taste Function and Eating Habits in Polycystic Ovary Syndrome
Contraceptive - Polycystic Ovary Syndrome
CompletedHacettepe University802020-01-152021-06-30
Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives
Tests of biological hemostatic profile associated with contraceptives - Venous Thromboembolism, Contraception
CompletedUniversity Hospital, Geneva1032018-10-082021-05-21
Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Etonogestrel-Immediate, Etonogestrel-Delayed - Postpartum Contraception, Family Planning
Phase 3CompletedStanford University952016-10-282022-07-25
Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women
Depo-Medroxyprogesterone Acetate, Progestin Contraceptive (Jadelle) - HIV, Contraception
Phase 4CompletedCenters for Disease Control and Prevention1312014-04-082018-03-19
Quickstart of Nexplanon® at Medical Abortion
Mifepristone, etonorgestrel - Early Pregnancy Termination, Medical Abortion
Phase 4CompletedKarolinska Institutet5512013-10-012016-02-25
Postpartum Etonogestrel Implant for Adolescents
Contraceptive implant - Adolescence, Contraception
Phase 4CompletedUniversity of North Carolina, Chapel Hill962012-08-012017-05-01
NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles
Contraceptives, Oral, Contraceptive, Vaginal ring - Infertility
Phase 4TerminatedClinique Ovo72012-07-012015-07-27
Assessment of Autonomic Tone in Normotensive Women Using Combined Hormonal Oral Contraceptive Containing Drospirenone
Contraceptives, Oral, Combined (Yaz®) - Contraceptive Affecting the Autonomic Nervous System, Contraceptive Affecting Blood Pressure
Phase 3UnknownInstituto do Coracao692011-01-012012-05-03

Conditions studied

Breast Feeding (1)  ·  Contraception Behavior (1)  ·  Infertility (1)  ·  Obesity (1)  ·  Polycystic Ovary Syndrome (1)  ·  Venous Thromboembolism (1)

Sponsors

Centers for Disease Control and Prevention (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Clinique Ovo (1)  ·  Hacettepe University (1)  ·  Instituto do Coracao (1)  ·  Karolinska Institutet (1)  ·  Novo Nordisk A/S (1)  ·  Stanford University (1)  ·  University Hospital, Geneva (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (3)  ·  Canada (2)  ·  Brazil (1)  ·  Malawi (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Athena P Kourtis, MD, PhD, MPH (1)  ·  Bulent Yildiz (1)  ·  Jacques Kadoch, MD (1)  ·  Jennifer Tang, MD, MSCR (1)  ·  Kate A Shaw, MD, MS (1)  ·  Kristina Gemzell-Danielsson, MD, PhD (1)  ·  Lameck Chinula, MD (1)  ·  Marcelo G Nisenbaum (1)

Results publications

PMID 16435003, PMID 26633243, PMID 27664217, PMID 29746813, PMID 31374188, PMID 36622252, PMID 36897226, PMID 37939264

NIH funding

2018 (1), K01TW009657 (1), U48DP001944 (1)